Searched for
ORAL ANTIVIRAL
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Hetero's oral drug gets WHO PrequalificationIt is the first prequalification for a generic version of Pfizer's Covid-19 oral antiviral drug paxlovid, the company said. The WHO made a ...
- Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptomsPfizer Inc Chief Executive Officer Albert Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid,...
- B'luru firm Bugworks begins work on drug against Covid-type virusesThe hunt for safe and effective Covid antivirals that can be used against Covid is on. Currently Pfizer's Paxlovid and MSD-Ridgeback Biothe...
- Phase III trials of COVID drug Movfor show positive results, says HeteroThe results, presented as an Oral Abstract at the Conference on Retroviruses and Opportunistic Infections (CROI) held virtually February 12...
- New antiviral drug combo highly effective against COVID-19: Study"Identifying combinations of antivirals is really important, not only because doing so may increase the drugs' potency against the coronavi...
- India to become hub for Covid-19 antiviral generic drugs: FitchGeneric molnupiravir will increase access in India and other low- and middle-income countries (LMICs), while simplifying current supply cha...
- Lupin launches Molnulup for COVID-19 treatmentMolnupiravir has been given emergency use authorisation by the Drug Controller General of India (DCGI) for treatment of adult COVID-19 pati...
- Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...
- Cipla to launch Molnupiravir under Cipmolnu brand name for COVID-19 treatment"This launch is yet another step in our endeavour to enable access to all treatments in COVID care. We continue to be guided by the power o...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- Indian pharma eyes affordable antiviral medicines to treat Covid-19The coronavirus is headed to the endemic stage in certain countries, giving these new drugs a potentially huge market, along with the abili...
- Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...
- Covid pills cannot do the job alone; disease experts say there's no substitute for vaccinesThe antiviral medications stop the virus from replicating in the body.
- India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...
- Dr Reddy’s warns public on spurious versions of 2DG, its anti-Covid drug, in the market“2DG is an oral antiviral drug that can be administered only upon prescription to hospitalized moderate to severe Covid-19 patients as adju...
- Pfizer begins early-stage study of oral drug to combat coronavirusThe drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate s...
- Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drugThe Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigat...
Load More
